2型糖尿病合并冠心病患者血糖、血清Metrnl蛋白水平变化及其与患者预后的相关性分析

doi:10.3969/j.issn.1671-7171.2024.10.008

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1343 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】The purpose of this study was to investigate the changes in blood glucose, serum Metrnl protein levels, and their correlation with prognosis in patients with type 2 diabetes mellitus (T2DM) complicated with coronary heart disease (CHD). 【Methods】A total of 102 patients with T2DM and CHD admitted to our hospital from March 2021 to March 2023 were selected and divided into the high-risk group (n=25), moderate-risk group (n=37), and low-risk group (n=40) according to the severity of the disease. The patients were further divided into a good prognosis group (n=79) and an unfavorable prognosis group (n=23) based on the prognosis. The baseline data, 24 h blood glucose, blood glucose fluctuation amplitude, and serum Metrnl protein levels of the groups were compared. The correlation between each indicator and prognosis was analyzed by Pearson correlation analysis. The factors affecting the prognosis of patients with T2DM and CHD were analyzed by Logistic regression analysis and a Receiver Operating Characteristic (ROC) curve was used to analyze the predictive ability of blood glucose and serum Metrnl protein levels in predicting the prognosis of patients with T2DM and CHD. 【Results】There were significant differences in 24 h blood glucose, blood glucose fluctuation amplitude, and serum Metrnl protein levels among the high-risk group, moderate-risk group, and low-risk group (P<0.05). The 24 h blood glucose, blood glucose fluctuation amplitude, and serum Metrnl protein level of the good prognosis group were lower than those of the unfavorable prognosis group (P<0.05). Pearson correlation analysis showed that the serum Metrnl protein level was negatively correlated with blood glucose fluctuation amplitude and 24 h blood glucose (P<0.05). The Logistic multivariate analysis results showed that 24 h blood glucose, blood glucose fluctuation amplitude, and serum Metrnl protein were influencing factors for the prognosis of patients with T2DM and CHD (P<0.05). The results of ROC curve analysis showed that the combined prediction of 24 h blood glucose, blood glucose fluctuation range and Metrnl protein in predicting the prognosis of patients with T2DM and CHD was significantly better than that of 24 h blood glucose, blood glucose fluctuation range and Metrnl protein alone. 【Conclusion】The blood glucose and serum Metrnl protein levels in patients with T2DM and CHD changed significantly with the severity of the disease and were significantly correlated with the prognosis of the patients.

Key words： Diabetes Mellitus, Type 2/CO Coronary Disease/CO Blood Glucose/AN Chemokines/AN Prognosis

Received: 26 December 2023

PACS:

R587.1

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Jiuming

Cite this article:

CHEN Jiuming. Analysis of Changes in Blood Glucose and Serum Metrnl Protein Levels in Patients with Type 2 Diabetes Complicated with Coronary Heart Disease and their Correlation with Prognosis[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(10): 1483-1486.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.10.008 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I10/1483

[1] 李小红,陈频. 新型脂肪细胞因子Metrnl在糖脂代谢中作用的研究进展[J].国际内分泌代谢杂志,2022,42(2):138-141.
[2] 魏巍,张皓,张旭,等. 血清Metrnl、RANTES水平与2型糖尿病患者并发冠心病的关系[J].山东医药,2022,62(31):40-44.
[3] 周密,龚艳琳,李伟,等. 利拉鲁肽联合二甲双胍治疗2型糖尿病合并冠心病的效果及对胰岛β细胞和心功能的影响[J].海军医学杂志,2020,41(2):196-198.
[4] 中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J] .中华心血管病杂志,2018,46(9):680-694.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(基层版)[J].中华全科医师杂志, 2013, 12(8): 675-696.
[6] 耿硕章,刘辉,朱贝利,等. 不同类型冠心病患者血浆可溶性CD146水平的检测及其临床意义[J].中国现代医学杂志,2022,32(7):6-12.
[7] 卢亚男,刘丽俊,高宇,等. 糖化白蛋白、糖化白蛋白/糖化血红蛋白与2型糖尿病合并冠心病相关性的研究[J].中国糖尿病杂志,2023,31(9):678-682.
[8] 周乐琴,徐慧琳,何伟喜. 2型糖尿病合并冠心病患者血清RBP、Lp(a)、NT-proBNP变化及对PCI术后近期主要不良心血管事件的预测[J].中国老年学杂志,2023,43(10):2305-2308.
[9] 田亚楠,孙莹,彭扬. TBiL及HbA1c在老年冠心病合并2型糖尿病中的水平及与冠状动脉不同病变程度的相关性[J].中国老年学杂志,2023,43(15):3635-3638.
[10] 阚春婷,曹长春. 糖尿病、冠心病患者Metrnl水平与糖脂代谢指标和部分炎性标志物水平的关系[J].国际检验医学杂志,2021,42(17):2113-2117.
[11] 郭剑平,匡林华,彭丹萍,等. 2型糖尿病伴冠心病患者血糖波动及血清Gal-3对主要不良心血管事件的预测价值[J].中国现代医学杂志,2022,32(23):90-96.
[12] 殷雪娇,徐阳星,徐秀容,等. 血清骨膜蛋白和骨硬化蛋白对老年2型糖尿病患者骨质疏松的诊断价值[J].中国现代医学杂志,2023,33(1):7-12.
[13] ZHAO M N, LI N, ZHOU H. SGLT1: a potential drug target for cardiovascular disease[J].Drug Des Devel Ther,2023: 2011-2023.
[14] 李苗,李宝新,王梦迪,等. 2型糖尿病合并冠心病患者血清Metrnl蛋白与天冬酰胺内肽酶水平变化及影响因素的研究[J].中国糖尿病杂志,2022,30(4):246-250.